Autor: "Alcalay RN" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Autorzy:: Alcalay RN; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
Wolf P; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
Chiang MSR; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.
Helesicova K; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
Zhang XK; Translational Sciences, Sanofi, Framingham, Massachusetts, USA.
Merchant K; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Hutten SJ; The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA.
Scherzer C; Advanced Center for Parkinson's Disease Research of Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Precision Neurology Program, Harvard Medical School, Brigham & Women's Hospital, Boston, Massachusetts, USA.; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA.
Blauwendraat C; Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
Foroud T; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Nudelman K; Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Gan-Or Z; Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada.; Montreal Neurological Institute and Hospital, McGill University, Montreal, Quebec, Canada.; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.
Simuni T; Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Chahine LM; Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Levy O; Department of Neurology, Columbia University Irving Medical Center New York, New York, USA.
Zheng D; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
Li G; Department of Biostatistics, Mailman School of Public Health, Columbia University Irving Medical Center New York, New York, USA.
Sardi SP; Rare and Neurological Diseases Therapeutic Area, Sanofi, Framingham, Massachusetts, USA.; Pokaż więcej
Corporate Authors:: Parkinson’s Progression Markers Initiative
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Oct; Vol. 7 (10), pp. 1816-1830. Date of Electronic Publication: 2020 Sep 05.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Dementia/*physiopathology
Glucosylceramidase/*metabolism
Parkinson Disease/*metabolism
Parkinson Disease/*pathology
Adult ; Dementia/complications ; Dementia/pathology ; Disease Progression ; Female ; Genotype ; Glucosylceramidase/genetics ; Heterozygote ; Humans ; Male ; Mental Status and Dementia Tests ; Middle Aged ; Mutation/genetics ; Parkinson Disease/complications ; Phenotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease.
Autorzy:: Weintraub D; Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Parkinson's Disease Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania.
Caspell-Garcia C; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa.
Simuni T; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Cho HR; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa.
Coffey CS; Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa.
Aarsland D; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, England.
Alcalay RN; Department of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, New York.
Barrett MJ; Department of Neurology, Virginia Commonwealth University, Richmond, Virginia.
Chahine LM; Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Eberling J; Michael J. Fox Foundation for Parkinson's Research, New York, New York.
Espay AJ; Department of Neurology, University of Cincinnati Academic Health Center, Cincinnati, Ohio.
Hamilton J; Michael J. Fox Foundation for Parkinson's Research, New York, New York.
Hawkins KA; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut.
Leverenz J; Lou Ruvo Center for Brain Health, Cleveland Clinic, Cleveland, Ohio.
Litvan I; UCSD Movement Disorder Center, Department of Neurosciences, University of California San Diego, San Diego, California.
Richard I; Departments of Neurology and Psychiatry, School of Medicine and Dentistry, University of Rochester, Rochester, New York.
Rosenthal LS; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Siderowf A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
York M; Departments of Neurology and Psychiatry & Behavioral Sciences, Baylor College of Medicine, Houston, Texas.; Pokaż więcej
Corporate Authors:: Parkinson’s Progression Markers Initiative
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2020 Apr; Vol. 7 (4), pp. 449-461. Date of Electronic Publication: 2020 Apr 13.
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Disease Progression*
Behavioral Symptoms/*physiopathology
Cognitive Dysfunction/*physiopathology
Parkinson Disease/*physiopathology
Adult ; Aged ; Aged, 80 and over ; Behavioral Symptoms/drug therapy ; Behavioral Symptoms/epidemiology ; Behavioral Symptoms/etiology ; Cognitive Dysfunction/drug therapy ; Cognitive Dysfunction/epidemiology ; Cognitive Dysfunction/etiology ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Parkinson Disease/complications ; Parkinson Disease/drug therapy ; Parkinson Disease/epidemiology ; Prevalence

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: GBA mutations are associated with Rapid Eye Movement Sleep Behavior Disorder.
Autorzy:: Gan-Or Z; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada.
Mirelman A; Department of Neurology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel.
Postuma RB; Department of Neurology, Montreal General Hospital Montréal, Quebec, Canada.
Arnulf I; Sleep Disorders Unit, Pitié Salpêtrière Hospital, Brain and Spine Institute and Sorbonne Universities, UPMC Paris 6 University Paris, France.
Bar-Shira A; The Genetic Institute, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel.
Dauvilliers Y; Sleep Unit, National Reference Network for Narcolepsy, Department of Neurology, Hôpital-Gui-de Chauliac, CHU Montpellier Montpellier, France.
Desautels A; Centre d'Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Cœur de Montréal Montréal, Quebec, Canada ; Department of Neurosciences, Université de Montréal Montréal, Canada.
Gagnon JF; Centre d'Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Cœur de Montréal Montréal, Quebec, Canada ; Département de psychologie, Université du Québec à Montréal Montréal, Quebec, Canada.
Leblond CS; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada.
Frauscher B; Sleep Disorders Clinic, Department of Neurology, Innsbruck Medical University Innsbruck, Austria.
Alcalay RN; Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University New York, New York.
Saunders-Pullman R; Department of Neurology, Icahn School of Medicine at Mount Sinai New York, New York ; Department of Neurology, Albert Einstein College of Medicine Bronx New York, New York.
Bressman SB; Department of Neurology, Beth Israel Medical Center New York, New York.
Marder K; Columbia Presbyterian Medical Center, Columbia University New York, New York.
Monaca C; Department of clinical neurophysiology and sleep center, University Lille north of France, CHU Lille Lille, France.
Högl B; Sleep Disorders Clinic, Department of Neurology, Innsbruck Medical University Innsbruck, Austria.
Orr-Urtreger A; The Genetic Institute, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel ; The Sackler Faculty of Medicine, Tel-Aviv University Tel-Aviv, Israel.
Dion PA; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada ; Department of Neurology and Neurosurgery, McGill University Montréal, Quebec, Canada.
Montplaisir JY; Centre d'Études Avancées en Médecine du Sommeil, Hôpital du Sacré-Cœur de Montréal Montréal, Quebec, Canada ; Department of Psychiatry, Université de Montréal Montréal, Quebec, Canada.
Giladi N; Department of Neurology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel ; The Sackler Faculty of Medicine, Tel-Aviv University Tel-Aviv, Israel.
Rouleau GA; Montreal Neurological Institute, McGill University Montréal, Quebec, Canada ; Department of Human Genetics, McGill University Montréal, Quebec, Canada ; Department of Neurology and Neurosurgery, McGill University Montréal, Quebec, Canada.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2015 Sep; Vol. 2 (9), pp. 941-5. Date of Electronic Publication: 2015 Jul 31.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?
Autorzy:: Saunders-Pullman R; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York ; Department of Neurology, Icahn School of Medicine at Mount Sinai New York City, New York ; Department of Neurology, Albert Einstein College of Medicine Bronx, New York.
Mirelman A; Movement Disorders Unit, Department of Neurology, Tel-Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University Tel-Aviv, Israel.
Wang C; Department of Epidemiology and Social Medicine, Albert Einstein College of Medicine Bronx, New York.
Alcalay RN; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York.
San Luciano M; Department of Neurology, University of California San Francisco San Francisco, California.
Ortega R; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York.
Raymond D; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York.
Mejia-Santana H; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York.
Ozelius L; Department of Neurology, Icahn School of Medicine at Mount Sinai New York City, New York ; Department of Genetics, Icahn School of Medicine at Mount Sinai New York City, New York.
Clark L; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York.
Orr-Utreger A; Genetic Institute, Tel-Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University Tel-Aviv, Israel.
Marder K; Department of Neurology, College of Physicians and Surgeons, Columbia University New York City, New York ; Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University New York City, New York ; Gertrude H. Sergievsky Center, College of Physicians and Surgeons, Columbia University New York City, New York ; Department of Psychiatry, Columbia University Medical Center New York City, New York.
Giladi N; Movement Disorders Unit, Department of Neurology, Tel-Aviv Medical Center, Sackler School of Medicine, Sagol School of Neuroscience, Tel-Aviv University Tel-Aviv, Israel.
Bressman SB; Department of Neurology, Mount Sinai Beth Israel Medical Center New York City, New York ; Department of Neurology, Icahn School of Medicine at Mount Sinai New York City, New York.; Pokaż więcej
Źródło:: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2014 Sep; Vol. 1 (9), pp. 670-8. Date of Electronic Publication: 2014 Sep 30.
Typ publikacji:: Journal Article

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Alcalay RN"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Język